Eczema and ceramides: an update. - Wikidata - awgldk - TriplyDB

Eczema and ceramides: an update.

Eczema and ceramides: an update.

http://www.wikidata.org/entity/Q34358580

about

Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic Targets Evaluation of a Pseudoceramide Moisturizer in Patients with Mild-to-Moderate Atopic Dermatitis.Local rhamnosoft, ceramides and L-isoleucine in atopic eczema: a randomized, placebo controlled trial

P2860

Q28276574-7AE507FD-41EC-4D01-9E0F-0260975DCE20 Q33785053-52A6C113-0792-4C80-A15A-C83D78D71BE3 Q34658901-AA97D2F8-27E8-4C7F-8A9D-344F9A51DC13

P2860

Eczema and ceramides: an update.

http://www.wikidata.org/entity/Q34358580

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Eczema and ceramides: an update.

@ast

Eczema and ceramides: an update.

@en

Eczema and ceramides: an update.

@nl

type

label

Eczema and ceramides: an update.

@ast

Eczema and ceramides: an update.

@en

Eczema and ceramides: an update.

@nl

prefLabel

Eczema and ceramides: an update.

@ast

Eczema and ceramides: an update.

@en

Eczema and ceramides: an update.

@nl

P1433

Q34358580-58F0D568-78E3-4BAB-A78F-606FD5CD7515

P1476

Q34358580-C9BFB8F8-927A-4FF5-8FC2-E51AE5AB281E

P2093

Q34358580-CE80247A-6A47-4536-81BD-5C6FF3CD3A13

P2860

Q34358580-0EC67074-0F5A-4030-8E20-2EB6FFE7537D

Q34358580-1018CC21-EB3F-4A9E-BB29-72DC705D4273

Q34358580-13BB356B-66A1-4BD7-9CE6-47AC91C96D09

Q34358580-1F15D75D-AA4D-4415-A37C-0F55D28F09F0

Q34358580-268219A4-1001-40EF-93A0-755DE889C48E

Q34358580-27680C49-FC6C-4679-97CB-57DC847F3402

Q34358580-2D1CD2CB-6AD0-44C3-9A64-B88B0C0F1071

Q34358580-2EB6569F-ADB8-4FDD-9855-83742B04AF20

Q34358580-302FAB8E-8BFC-4E67-8329-BDD6875D6C69

Q34358580-34CE51AD-AC69-4552-A40C-FB74FE2925DE

P304

Q34358580-46CCF90C-E509-4184-922A-FFE6479A2CC5

P31

Q34358580-44B0F32D-B759-4FA8-8E84-E87081A25ADB

P356

Q34358580-F0E22209-3BA3-49FC-B78D-20BA0C3E9A46

P433

Q34358580-74010AB4-79E5-445E-A803-A5CC924DA99A

P478

Q34358580-7B3F923F-0455-4409-93E7-65AD7F9D8B10

P50

Q34358580-9CACB55E-58D2-465C-8650-6D0FD2ACB10C

P577

Q34358580-A3775482-1FE2-4BDB-8311-855AC70E94F2

P698

Q34358580-4903D300-6081-4B1D-8B44-CA7902D12987

P356

P1433

Contact Dermatitis

P1476

Eczema and ceramides: an update

@en

P2093

Jakob Mutanu Jungersted

http://www.w3.org/2001/XMLSchema#string

P2860

Ceramide stimulates ABCA12 expression via peroxisome proliferator-activated receptor {delta} in human keratinocytes

Short-term effects of alcohol-based disinfectant and detergent on skin irritation

The skin: an indispensable barrier

Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis

Investigation of the molecular structure of the human stratum corneum ceramides [NP] and [EOS] by mass spectrometry.

Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three.

The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramide

The acidic milieu of the horny layer: new findings on the physiology and pathophysiology of skin pH.

Skin reactions to irritants assessed by non-invasive bioengineering methods.

The clinical benefit of moisturizers.

P304

65-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/COD.12073

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23869725

http://www.w3.org/2001/XMLSchema#string